ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 763587 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 763587; 2) Community: the network communities that were significantly associated with the response to NSC 763587; 3) Molecule: the relationships between components within communities and NSC 763587; 4) MDR: the compounds that were significantly associated with the NSC 763587.

NSC Compound Enrichment Correlation
NSC 744693 Null 0.0388857481216096 0.27774178
NSC 745943 Null 0.0388857481216096 -0.16737258
NSC 749245 N-(3-{(2E)-3-[4-(diethylamino)phenyl]prop-2-enoyl}phenyl)methanesulfonamide 0.0388857481216096 0.28640408
NSC 75520 Thymidine, .alpha.,.alpha.,.alpha.-trifluoro- (8CI 9CI) 0.0388857481216096 0.44396272
NSC 763564 EMD-534085 0.0388857481216096 0.10055657
NSC 85235 10.alpha.H-Ambrosa-2,11(13)-dien-12-oic acid, 6.beta.-hydroxy-4-oxo-, .gamma.-lactone (8CI) 0.03888574812161 0.41929605
NSC 87500 Solacongestidine 0.03888574812161 0.45069195
NSC 625350 Benzenepropanoic acid, .beta.-(benzoylamino)-.alpha.- hydroxy-, (9,10-dihydro-9,10-dioxo-2-anthracenyl)methyl ester (R*,R*) 0.0420893367628868 -0.47018302
NSC 637603 2H-1,4-Benzothiazin-3-one, 3,4-dihydro-2-[2-[(2,5-dimethylphenyl)amino]-2-oxoethyl]- 0.0420893367628868 -0.47385262
NSC 676497 TP4EK 0.0420893367628868 -0.30997938
Total:132  Current:119    [First] [Prev] [Next] [Last]